Cerebral microvascular IL15 is a novel mediator of TNF action

Journal of Neurochemistry

Volumn 111, Issue 3, 2009, Pages 819-827

  Pan, Weihong ^a   Yu, Chuanhui ^a   Hsuchou, Hung ^a   Khan, Reas S ^a   Kastin, Abba J ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Blood brain barrier; Cytokine; Endocytosis; Interleukin 15; Microarray; Signaling; Tumor necrosis factor

Indexed keywords

ALEXA 568; FLUORESCEIN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 15 RECEPTOR BETA; INTERLEUKIN 15 RECEPTOR GAMMA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN BLOOD VESSEL; CELL ADHESION; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE; GENE EXPRESSION; MEDIATOR; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TRANSFORMED; CEREBRAL CORTEX; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; INTERLEUKIN-15; MICROVESSELS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RECEPTORS, INTERLEUKIN-15; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTORS; UP-REGULATION;

MUS; PYRONIA TITHONUS;

EID: 70349920962     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06371.x     Document Type: Article

References (67)

1. Auernhammer C. J., Kopp F. B., Vlotides G., Dorn F., Isele N. B., Spottl G., Cengic N., Weber M. M., Senaldi G. Engelhardt D. (2004) Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells-redundancy or specificity of neuroimmunoendocrine modulators? Neuroimmunomodulation 11, 224 232.
2. Banks W. A., Kastin A. J. Gutierrez E. G. (1994) Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 179, 53 56.
3. Barton V. A., Hall M. A., Hudson K. R. Heath J. K. (2000) Interleukin-11 signals through the formation of a hexameric receptor complex. J. Biol. Chem. 275, 36197 36203.
4. Beck R. D. Jr., Wasserfall C., Ha G. K., Cushman J. D., Huang Z., Atkinson M. A. Petitto J. M. (2005) Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice. Brain Res. 1041, 223 230.
5. Budagian V., Bulanova E., Paus R. Bulfone-Paus S. (2006) IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 17, 259 280.
6. Bulfone-Paus S., Bulanova E., Pohl T., Budagian V., Durkop H., Ruckert R., Kunzendorf U., Paus R. Krause H. (1999) Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J. 13, 1575 1585.
7. Du X., Everett E. T., Wang G., Lee W. H., Yang Z. Williams D. A. (1996) Murine interleukin-11 (IL-11) is expressed at high levels in the hippocampus and expression is developmentally regulated in the testis. J. Cell. Physiol. 168, 362 372.
8. Durieu-Trautmann O., Chaverot N., Cazaubon S., Strosberg D. Couraud P.-O. (1994) Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J. Biol. Chem. 269, 12536 12540.
9. Ebert E. C. Jabri B. (2008) Massive interleukin-12-induced interferon-gamma production by interleukin-15-stimulated lamina propria lymphocytes followed by down-regulation of the interleukin-12 receptor. Immunology 124, 453 460.
10. Fehniger T. A. Caligiuri M. A. (2001) Interleukin 15: biology and relevance to human disease. Blood 97, 14 32.
11. Gaggero A., Azzarone B., Andrei C., Mishal Z., Meazza R., Zappia E., Rubartelli A. Ferrini S. (1999) Differential intracellular trafficking, secretion and endosomal localization of two IL-15 isoforms. Eur. J. Immunol. 29, 1265 1274.
12. Giri J., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L., Cosman D. Anderson D. (1994) Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13, 2822 2830.
13. Giron-Michel J., Caignard A., Fogli M. et al. (2003) Differential STAT3, STAT5, and NF-kappaB activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules. Blood 102, 109 117.
14. Gutierrez E. G., Banks W. A. Kastin A. J. (1993) Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47, 169 176.
15. Hanisch U. K., Lyons S. A., Prinz M., Nolte C., Weber J. R., Kettenmann H. Kirchhoff F. (1997) Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus kinase activity. J. Biol. Chem. 272, 28853 28860.
16. Hemar A., Subtil A., Lieb M., Morelon E., Hellio R. Dautry-Varsat A. (1995) Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains. J. Cell Biol. 129, 55 64.
17. Hsuchou H., Pan W., Wu X. Kastin A. J. (2009) Cessation of blood-to-brain influx of interleukin-15 during development of EAE. J. Cereb. Blood Flow Metab. PMID: 19536071.
18. de Jong J., Farner N., Widmer M., Giri J. Sondel P. (1996) Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. The IL-15/beta/gamma c receptor-ligand complex is less stable than the IL-2/beta/gamma c receptor-ligand complex. J. Immunol. 156, 1339 1348.
19. Joshi P. C., Zhou X., Cuchens M. Jones Q. (2001) Prostaglandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common gamma-chain. J. Immunol. 166, 885 891.
20. Kennedy M. K., Glaccum M., Brown S. N. et al. (2000) Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771 780.
21. Kubota T., Brown R. A., Fang J. Krueger J. M. (2001) Interleukin-15 and interleukin-2 enhance non-REM sleep in rabbits. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1004 R1012.
22. Kurys G., Tagaya Y., Bamford R., Hanover J. Waldmann T. (2000) The long signal peptide isoform and its alternative processing direct the intracellular trafficking of interleukin-15. J. Biol. Chem. 275, 30653 30659.
23. Lee Y. B., Satoh J., Walker D. G. Kim S. U. (1996) Interleukin-15 gene expression in human astrocytes and microglia in culture. NeuroReport 7, 1062 1066.
24. Linker R. A., Luhder F., Kallen K. J., Lee D. H., Engelhardt B., Rose-John S. Gold R. (2008) IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier. J. Neuroimmunol. 205, 64 72.
25. Mark K. S., Trickler W. J. Miller D. W. (2001) Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells. J. Pharmacol. Exp. Ther. 297, 1051 1058.
26. Maslinska D. (2001) The cytokine network and interleukin-15 (IL-15) in brain development. Folia Neuropathol. 39, 43 47.
27. Mayo M. W., Wang C. Y., Cogswell P. C., Rogers-Graham K. S., Lowe S. W., Der C. J. Baldwin A. S. Jr. (1997) Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278, 1812 1815.
28. Mizushima H., Banks W. A., Dohi K., Shioda S. Matsumoto K. (1999) Effect of cardiac arrest on brain weight and the permeability of the blood-brain barrier and blood-spinal cord barrier to albumin and tumor necrosis factor-alpha. Life Sci. 65, 2127 2134.
29. Nielsen M., Nordahl M., Svejgaard A. Odum N. (1998) Interleukin 2 and 15 activate Stat3alpha in human T lymphocytes. Cytokine 10, 735 738.
30. Onu A., Pohl T., Krause H. Bulfone-Paus S. (1997) Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J. Immunol. 158, 255 262.
31. Osburg B., Peiser C., Dömling D., Schomburg L., Ko Y. T., Viogt K. Bickel U. (2002) Effect of endotoxin on expression of TNF receptors and transport of TNF-α at the blood-brain barrier of the rat. Am. J. Physiol. 283, E899 E908.
32. Paik Y. H., Lee K. S., Lee H. J. et al. (2006) Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid. Lab. Invest. 86, 676 686.
33. Pan W. Kastin A. J. (2002) TNFα transport across the blood-brain barrier is abolished in receptor knockout mice. Exp. Neurol. 174, 193 200.
34. Pan W. Kastin A. J. (2007a) Adipokines and the blood-brain barrier. Peptides 28, 1317 1330.
35. Pan W. Kastin A. J. (2007b) Tumor necrosis factor and stroke: role of the blood-brain barrier. Prog. Neurobiol. 83, 363 374.
36. Pan W., Banks W. A., Kennedy M. K., Gutierrez E. G. Kastin A. J. (1996) Differential permeability of the BBB in acute EAE: enhanced transport of TNF-α. Am. J. Physiol. 271, E636 E642.
37. Pan W., Banks W. A. Kastin A. J. (1997a) Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury. Exp. Neurol. 146, 367 373.
38. Pan W., Banks W. A. Kastin A. J. (1997b) Permeability of the blood-brain and blood-spinal cord barriers to interferons. J. Neuroimmunol. 76, 105 111. (Pubitemid 27272635)
39. Pan W., Zadina J. E., Harlan R. E., Weber J. T., Banks W. A. Kastin A. J. (1997c) Tumor necrosis factor α: a neuromodulator in the CNS. Neurosci. Biobehav. Rev. 21, 603 613.
40. Pan W., Kastin A. J., Bell R. L. Olson R. D. (1999) Upregulation of tumor necrosis factor α transport across the blood-brain barrier after acute compressive spinal cord injury. J. Neurosci. 19, 3649 3655.
41. Pan W., Csernus B. Kastin A. J. (2003a) Upregulation of p55 and p75 receptors mediating TNF alpha transport across the injured blood-spinal cord barrier. J. Mol. Neurosci. 21, 173 184.
42. Pan W., Kastin A. J., McLay R. N., Rigai T. Pick C. G. (2003b) Increased hippocampal uptake of TNFα and behavioral changes in mice. Exp. Brain Res. 149, 195 199.
43. Pan W., Yu Y., Cain C. M., Nyberg F., Couraud P.-O. Kastin A. J. (2005) Permeation of growth hormone across the blood-brain barrier. Endocrinology 146, 4898 4904.
44. Pan W., Ding Y., Yu Y., Ohtaki H., Nakamachi T. Kastin A. J. (2006a) Stroke upregulates TNF alpha transport across the blood-brain barrier. Exp. Neurol. 198, 222 233.
45. Pan W., Tu H. Kastin A. J. (2006b) Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 27, 911 916.
46. Pan W., Kastin A. J., Daniel J., Yu C., Baryshnikova L. M. von Bartheld C. S. (2007a) TNF alpha trafficking in cerebral vascular endothelial cells. J. Neuroimmunol. 185, 47 56. (Pubitemid 46497436)
47. Pan W., Tu H., Yu C., Hsuchou H., Yang Y. Kastin A. J. (2007b) Differential role of TNF receptors in cellular trafficking of intact TNF. Cell. Phyiosiol. Biochem. 20, 559 568.
48. Pan W., Hsuchou H., Yu C. Kastin A. J. (2008) Permeation of blood-borne IL15 across the blood-brain barrier and the effect of LPS. J. Neurochem. 106, 313 319. (Pubitemid 351840214)
49. Pereno R., Giron-Michel J., Gaggero A. et al. (2000) IL-15/IL-15Ralpha intracellular trafficking in human melanoma cells and signal transduction through the IL-15Ralpha. Oncogene 19, 5153 5162.
50. Qin J. Z., Kamarashev J., Zhang C. L., Dummer R., Burg G. Dobbeling U. (2001) Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J. Invest. Dermatol. 117, 583 589.
51. Rentzos M., Cambouri C., Rombos A., Nikolaou C., Anagnostouli M., Tsoutsou A., Dimitrakopoulos A., Triantafyllou N. Vassilopoulos D. (2006) IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. J. Neurol. Sci. 241, 25 29. (Pubitemid 43112512)
52. Sasaki C. Y., Slemenda C. F., Ghosh P., Barberi T. J. Longo D. L. (2007) Traf1 induction and protection from tumor necrosis factor by nuclear factor-kappaB p65 is independent of serine 536 phosphorylation. Cancer Res. 67, 11218 11225.
53. Satoh J., Kurohara K., Yukitake M. Kuroda Y. (1998) Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues. J. Neurol. Sci. 155, 170 177.
54. Schwabe M., Zhao J. Kung H. F. (1994) Differential expression and ligand-induced modulation of the human interleukin-6 receptor on interleukin-6-responsive cells. J. Biol. Chem. 269, 7201 7209.
55. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T. Kishimoto T. (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58, 573 581.
56. Tagaya Y., Kurys G., Thies T. A., Losi J. M., Azimi N., Hanover J. A., Bamford R. N. Waldmann T. A. (1997) Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc. Natl Acad. Sci. USA 94, 14444 14449.
57. Takeda K. Akira S. (2004) TLR signaling pathways. Semin. Immunol. 16, 3 9.
58. Trickler W. J., Mayhan W. G. Miller D. W. (2005) Brain microvessel endothelial cell responses to tumor necrosis factor-alpha involve a nuclear factor kappa B (NF-kappaB) signal transduction pathway. Brain Res. 1048, 24 31.
59. Tu H., Kastin A. J. Pan W. (2007a) CRH-R1 and CRH-R2 are both trafficking and signaling receptors for urocortin. Mol. Endocrinol. 21, 700 711.
60. Tu H., Pan W., Feucht L. Kastin A. J. (2007b) Convergent trafficking pattern of leptin after endocytosis mediated by ObRa - ObRd. J. Cell. Physiol. 212, 215 222.
61. Verma S., Nakaoke R., Dohgu S. Banks W. A. (2006) Release of cytokines by brain endothelial cells: a polarized response to lipopolysaccharide. Brain Behav. Immun. 20, 449 455.
62. Yu C., Kastin A. J., Couraud P.-O. Pan W. (2006) Cell-type specific response to hypoxia in relation to differential cytokine receptor expression. Society for Neuroscience abstract, Atlanta, GA, USA.
63. Yu C., Kastin A. J., Ding Y. Pan W. (2007a) Gamma glutamyl transpeptidase is a dynamic indicator of endothelial response to stroke. Exp. Neurol. 203, 116 122.
64. Yu C., Kastin A. J. Pan W. (2007b) TNF reduces LIF endocytosis despite increasing NFkappaB-mediated gp130 expression. J. Cell. Physiol. 213, 161 166.
65. Yu C., Kastin A. J., Tu H. Pan W. (2007c) Opposing effects of proteasomes and lysosomes on LIFR: modulation by TNF. J. Mol. Neurosci. 32, 80 89.
66. Yu C., Pan W., Tu H., Waters S. Kastin A. J. (2007d) TNF activates MDR1 (P-glycoprotein) in cerebral microvascular endothelial cells. Cell Physiol. Biochem. 20, 853 858. (Pubitemid 350059728)
67. Yu C., Argyropoulos G., Zhang Y., Kastin A. J., Hsuchou H. Pan W. (2008) Neuroinflammation activates Mdr1b efflux transport through NFkappaB: promoter analysis in BBB endothelia. Cell Physiol. Biochem. 22, 745 756.